“Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia After BTK Inhibitor and/or BCL-2 Inhibitor Failure” (2024) Canadian Hematology Today, 3(2), pp. 49–53. doi:10.58931/cht.2024.3255.